Aligos Therapeutics (ALGS) Current Deferred Tax Assets (2022 - 2024)
Aligos Therapeutics' Current Deferred Tax Assets was -$56.52 million in Q4 2024, compared with -$34.24 billion a year earlier.
Analysis
Aligos Therapeutics (ALGS) Current Deferred Tax Assets (2022 - 2024) Analysis & Trends
- In earlier years, Current Deferred Tax Assets was -$34.24 billion in FY2023 and -$109.56 billion in FY2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn |
| 10 | Aligos Therapeutics | 21.97 Mn | -314.86 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | -56.52 Mn |
| Dec 31, 2023 | -34.24 Bn |
| Dec 31, 2022 | -109.56 Bn |
API Access
Aligos Therapeutics Current Deferred Tax Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-tax-assets&ticker=ALGS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-tax-assets", "ticker": "ALGS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-tax-assets&ticker=ALGS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();